These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 1317026)

  • 1. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
    Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
    Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
    Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
    Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
    Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
    Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feedback inhibition of met-enkephalin release from the rat spinal cord in vivo.
    Collin E; Bourgoin S; Mantelet S; Hamon M; Cesselin F
    Synapse; 1992 May; 11(1):76-84. PubMed ID: 1604425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats.
    Ballet S; Mauborgne A; Hamon M; Cesselin F; Collin E
    Synapse; 2000 Sep; 37(4):262-72. PubMed ID: 10891863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation.
    Benoliel JJ; Bourgoin S; Mauborgne A; Legrand JC; Hamon M; Cesselin F
    Neurosci Lett; 1991 Apr; 124(2):204-7. PubMed ID: 1648690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
    Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
    Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid control of the release of Met-enkephalin-like material from the rat spinal cord.
    Bourgoin S; Collin E; Benoliel JJ; Chantrel D; Mauborgne A; Pohl M; Hamon M; Cesselin F
    Brain Res; 1991 Jun; 551(1-2):178-84. PubMed ID: 1655159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat.
    Hope PJ; Fleetwood-Walker SM; Mitchell R
    Br J Pharmacol; 1990 Oct; 101(2):477-83. PubMed ID: 2175238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of kappa-mediated antitussive activity in rats by a delta-agonist.
    Kamei J; Tanihara H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):375-8. PubMed ID: 1321982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intrathecal mu, delta, and kappa agonists on thermally evoked cardiovascular and nociceptive reflexes in halothane-anesthetized rats.
    Nagasaka H; Yaksh TL
    Anesth Analg; 1995 Mar; 80(3):437-43. PubMed ID: 7864404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
    Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
    Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
    Yuan CS
    Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats.
    Hoffman DC; West TE; Wise RA
    Brain Res; 1991 Jun; 550(2):205-12. PubMed ID: 1653084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.